These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10457846)

  • 1. Strep-tag II for one-step affinity purification of active bHLHzip domain of human c-Myc.
    Zwicker N; Adelhelm K; Thiericke R; Grabley S; Hänel F
    Biotechniques; 1999 Aug; 27(2):368-75. PubMed ID: 10457846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
    Farina A; Faiola F; Martinez E
    Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.
    Zinzalla G
    Methods Mol Biol; 2021; 2318():21-43. PubMed ID: 34019285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization.
    Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM
    J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
    J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ; Halazonetis TD
    Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR.
    Draeger LJ; Mullen GP
    J Biol Chem; 1994 Jan; 269(3):1785-93. PubMed ID: 8294427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of dominant negatives to bHLHZip proteins that inhibit DNA binding.
    Krylov D; Echlin DR; Taparowsky EJ; Vinson C
    Curr Top Microbiol Immunol; 1997; 224():169-77. PubMed ID: 9308240
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking myc to the max.
    Turner R
    Nat Struct Biol; 2003 Mar; 10(3):157. PubMed ID: 12605219
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of the Twin-Strep-tag® and its application for purification of recombinant proteins from cell culture supernatants.
    Schmidt TG; Batz L; Bonet L; Carl U; Holzapfel G; Kiem K; Matulewicz K; Niermeier D; Schuchardt I; Stanar K
    Protein Expr Purif; 2013 Nov; 92(1):54-61. PubMed ID: 24012791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
    Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.